TP Biosciences offers a specialized range of recombinant fusion proteins, designed to enhance protein stability, solubility, bioactivity, and detection in research, diagnostics, and therapeutic development. These proteins combine functional domains or tags to improve their application in immunotherapy, drug discovery, and molecular biology.

Key Categories of Fusion Proteins:

• Immune Checkpoint Fusion Proteins – PD-1 Fc, PD-L1 Fc, CTLA-4 Fc
  Used in immuno-oncology research and drug screening assays.
• Cytokine & Growth Factor Fusion Proteins – IL-2 Fc, VEGF Fc, TGF-β Fc
  Enhance protein stability and therapeutic potential in cell culture and regenerative medicine.
• Receptor-Ligand Fusion Proteins – TNFR-Fc, EGFR-Fc, CD40L-Fc
  Facilitate interaction studies and therapeutic target validation.
• Enzyme Fusion Proteins – Cas9-GFP, HRP-Fc, β-Gal-His
  Improve enzymatic activity detection and intracellular tracking.
• Tag-Enhanced Fusion Proteins – GST, MBP, His, FLAG, GFP fusions
  Aid in purification, solubility, and visualization in molecular biology applications.
• Vaccine & Antigen Fusion Proteins – SARS-CoV-2 RBD-Fc, HIV gp120-Fc
  Enhance immunogenicity and stability in vaccine research.

Why Choose TP Biosciences Fusion Proteins?

• High Purity & Functional Validation – Ensures reproducibility in experiments.
• Diverse Expression Systems – Mammalian, bacterial, and insect cell expression.
• Endotoxin-Free (<0.1 EU/µg) – Suitable for cell-based and in vivo applications.
• Custom Fusion Protein Development – Tailored solutions to meet specific research needs.